347 related articles for article (PubMed ID: 34710243)
21. How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors.
Falini B; De Carolis L; Tiacci E
Blood; 2022 Apr; 139(15):2294-2305. PubMed ID: 35143639
[TBL] [Abstract][Full Text] [Related]
22. [Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?].
Troussard X; Maitre E; Paillassa J
Bull Cancer; 2021; 108(7-8):771-778. PubMed ID: 34023063
[TBL] [Abstract][Full Text] [Related]
23. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
[TBL] [Abstract][Full Text] [Related]
24. Hairy Cell Leukaemia.
Cross M; Dearden C
Curr Oncol Rep; 2020 Apr; 22(5):42. PubMed ID: 32297104
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
[TBL] [Abstract][Full Text] [Related]
26. Immunoconjugates and new molecular targets in hairy cell leukemia.
Kreitman RJ
Hematology Am Soc Hematol Educ Program; 2012; 2012():660-6. PubMed ID: 23233649
[TBL] [Abstract][Full Text] [Related]
27. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
Pettirossi V; Santi A; Imperi E; Russo G; Pucciarini A; Bigerna B; Schiavoni G; Fortini E; Spanhol-Rosseto A; Sportoletti P; Mannucci R; Martelli MP; Klein-Hitpass L; Falini B; Tiacci E
Blood; 2015 Feb; 125(8):1207-16. PubMed ID: 25480661
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
[TBL] [Abstract][Full Text] [Related]
29. How I manage patients with hairy cell leukaemia.
Thompson PA; Ravandi F
Br J Haematol; 2017 May; 177(4):543-556. PubMed ID: 28146266
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hairy cell leukemia.
Chihara D; Kreitman RJ
Expert Rev Hematol; 2020 Oct; 13(10):1107-1117. PubMed ID: 32893700
[TBL] [Abstract][Full Text] [Related]
31. Immunoconjugates in the management of hairy cell leukemia.
Kreitman RJ; Pastan I
Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
[TBL] [Abstract][Full Text] [Related]
32. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.
Tiacci E; Schiavoni G; Forconi F; Santi A; Trentin L; Ambrosetti A; Cecchini D; Sozzi E; Francia di Celle P; Di Bello C; Pulsoni A; Foà R; Inghirami G; Falini B
Blood; 2012 Jan; 119(1):192-5. PubMed ID: 22028477
[TBL] [Abstract][Full Text] [Related]
33. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract][Full Text] [Related]
34. Genomics of Hairy Cell Leukemia.
Tiacci E; Pettirossi V; Schiavoni G; Falini B
J Clin Oncol; 2017 Mar; 35(9):1002-1010. PubMed ID: 28297625
[TBL] [Abstract][Full Text] [Related]
35. [Molecular and therapeutic advances in Hairy cell leukemia].
Balsat M; Cornillon J
Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
[TBL] [Abstract][Full Text] [Related]
36. Hairy Cell Leukemia: Where Are We in 2023?
Mendez-Hernandez A; Moturi K; Hanson V; Andritsos LA
Curr Oncol Rep; 2023 Aug; 25(8):833-840. PubMed ID: 37097545
[TBL] [Abstract][Full Text] [Related]
37. Hairy cell leukemia: present and future directions.
Kreitman RJ
Leuk Lymphoma; 2019 Dec; 60(12):2869-2879. PubMed ID: 31068044
[TBL] [Abstract][Full Text] [Related]
38. [Hairy cell leukemia].
Maitre E; Wiber M; Cornet E; Troussard X
Presse Med; 2019; 48(7-8 Pt 1):842-849. PubMed ID: 31447330
[TBL] [Abstract][Full Text] [Related]
39. Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials.
Robak T; Robak P
Expert Opin Investig Drugs; 2023 Apr; 32(4):311-324. PubMed ID: 36931901
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
